This week in the U.S. stock market, the pharmaceutical and biotech sectors have seen significant developments. Key topics such as new drug developments, upcoming FDA approvals, and mergers and acquisitions (M&A) have drawn the attention of investors. Below is a detailed summary of the major issues that made headlines this week. 1. Upcoming FDA Approvals […]